Table 3 Shown are the functional validation results for 21 TFs enriched (at FDR ≤0.1 and P-value ≤0.05) for either taxane, paclitaxel (PAX) or docetaxel (DOC)
From: Computational discovery of transcription factors associated with drug response
Number | TF | GENMi enrichments | Cell lines | ||||||
|---|---|---|---|---|---|---|---|---|---|
PAX | DOC | BTF549 | MDA-MB-231 | ||||||
P-value | FDR | P-value | FDR | PAX | DOC | PAX | DOC | ||
1 | BATF | 0.0142 | 0.07 | 0.5160 | 1.00 | UP | UP | ||
2 | BCL3 | 0.4112 | 0.56 | 0.0020 | 0.03 | UP | UP | UP | UP |
3 | BHLHE40 | 0.0088 | 0.06 | 0.0487 | 0.30 | UP | UP | ||
4 | CEBPB | 0.0024 | 0.02 | 0.3199 | 0.86 | UP | UP | UP | UP |
5 | ELF1 | 0.0020 | 0.03 | 0.0147 | 0.20 | UP | UP | UP | UP |
6 | FOS | 0.0127 | 0.09 | 0.2007 | 0.63 | UP | UP | ||
7 | FOSL2 | 0.0285 | 0.12 | 0.0012 | 0.03 | UP | UP | ||
8 | FOXM1 | 0.2754 | 0.44 | 0.0052 | 0.07 | UP | UP | UP | |
9 | IKZF1 | 0.0213 | 0.09 | 0.1422 | 0.78 | UP | UP | ||
10 | KDM5B | 0.0016 | 0.02 | 0.0004 | 0.04 | UP | UP | ||
11 | MAFK | 0.0016 | 0.02 | 0.6006 | 1.00 | UP | UP | UP | UP |
12 | MTA3 | 0.0027 | 0.03 | 0.1556 | 0.62 | UP | UP | UP | |
13 | NFIC | 0.0020 | 0.02 | 0.0131 | 0.18 | UP | UP | UP | UP |
14 | RBBP5 | 0.0012 | 0.02 | 0.3613 | 0.69 | UP | |||
15 | REST | 0.0008 | 0.04 | 0.2343 | 0.57 | UP | UP | UP | UP |
16 | SIN3A | 0.0028 | 0.03 | 0.5193 | 0.78 | UP | |||
17 | TBL1XR1 | 0.0071 | 0.04 | 0.5347 | 1.00 | ||||
18 | TCF7L2 | 0.0056 | 0.04 | 0.1004 | 0.45 | UP | |||
19 | WRNIP1 | 0.0004 | 0.02 | 0.2273 | 0.59 | UP | UP | UP | |
20 | ZBTB33 | 0.0044 | 0.05 | 0.9282 | 0.95 | UP | UP | ||
21 | ZNF263 | 0.0168 | 0.09 | 0.0255 | 0.26 | UP | UP | ||